{"title":"The link between hyperuricemia and diabetes: insights from a quantitative analysis of scientific literature.","authors":"Lili Ma, Jing Wang, Li Ma, Xian Min Wang","doi":"10.3389/fendo.2024.1441503","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hyperuricemia (HUA) is a significant public health issue, ranking second only to diabetes in prevalence. While existing research demonstrates a robust correlation between these two conditions, the precise etiological mechanisms remain inadequately elucidated. This study utilized scientometric analysis to investigate the global association between HUA and diabetes.</p><p><strong>Methods: </strong>Data on HUA and diabetes were retrieved from the Web of Science Core Collection database, encompassing the period from its inception until September 30, 2024. Collaboration networks were examined using VOSviewer, cluster analysis was executed with CiteSpace, and systematic mapping was conducted using Bibliometrix.</p><p><strong>Results: </strong>By September 30, 2024, 1,464 studies indicated a consistent yearly increase in publications connecting HUA and diabetes despite some fluctuations. The lead authors were Richard J. Johnson, Miguel A. Lanaspa, and Masanari Kuwabara, with most contributors from China, the United States, and Japan. Key institutions include China Medical University, Shanghai Jiao Tong University, and Capital Medical University. The most published journal was Nutrition, Metabolism and Cardiovascular Diseases (CVDs), whereas the most cited journal was Diabetes Care. The reference network from 1987 to September 30, 2024, identified 19 clusters highlighting key research areas in HUA and diabetes, such as metabolic syndrome, uropathology, chronic kidney disease (CKD), and CVD. Exploring pathological mechanisms and pharmacological interventions linked to diabetes concomitant with HUA has emerged as a focal point of research and a burgeoning trend within the field.</p><p><strong>Conclusion: </strong>This study is the first scientometric analysis to synthesize research trends on HUA and diabetes, revealing molecular mechanisms and treatment strategies and providing theoretical insights for future clinical use.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1441503"},"PeriodicalIF":4.6000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11842261/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fendo.2024.1441503","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Hyperuricemia (HUA) is a significant public health issue, ranking second only to diabetes in prevalence. While existing research demonstrates a robust correlation between these two conditions, the precise etiological mechanisms remain inadequately elucidated. This study utilized scientometric analysis to investigate the global association between HUA and diabetes.
Methods: Data on HUA and diabetes were retrieved from the Web of Science Core Collection database, encompassing the period from its inception until September 30, 2024. Collaboration networks were examined using VOSviewer, cluster analysis was executed with CiteSpace, and systematic mapping was conducted using Bibliometrix.
Results: By September 30, 2024, 1,464 studies indicated a consistent yearly increase in publications connecting HUA and diabetes despite some fluctuations. The lead authors were Richard J. Johnson, Miguel A. Lanaspa, and Masanari Kuwabara, with most contributors from China, the United States, and Japan. Key institutions include China Medical University, Shanghai Jiao Tong University, and Capital Medical University. The most published journal was Nutrition, Metabolism and Cardiovascular Diseases (CVDs), whereas the most cited journal was Diabetes Care. The reference network from 1987 to September 30, 2024, identified 19 clusters highlighting key research areas in HUA and diabetes, such as metabolic syndrome, uropathology, chronic kidney disease (CKD), and CVD. Exploring pathological mechanisms and pharmacological interventions linked to diabetes concomitant with HUA has emerged as a focal point of research and a burgeoning trend within the field.
Conclusion: This study is the first scientometric analysis to synthesize research trends on HUA and diabetes, revealing molecular mechanisms and treatment strategies and providing theoretical insights for future clinical use.
背景:高尿酸血症(HUA)是一个重要的公共卫生问题,患病率仅次于糖尿病。虽然现有的研究表明这两种情况之间存在强大的相关性,但确切的病因机制仍未充分阐明。本研究利用科学计量学分析来调查HUA与糖尿病之间的全球关系。方法:从Web of Science Core Collection数据库中检索HUA和糖尿病的数据,时间跨度从数据库建立到2024年9月30日。使用VOSviewer检查协作网络,使用CiteSpace进行聚类分析,使用Bibliometrix进行系统制图。结果:截至2024年9月30日,1464项研究表明,尽管有一些波动,但将HUA和糖尿病联系起来的出版物仍在逐年增加。主要作者是Richard J. Johnson、Miguel A. Lanaspa和Masanari Kuwabara,主要贡献者来自中国、美国和日本。重点院校包括中国医科大学、上海交通大学和首都医科大学。发表最多的期刊是《营养、代谢和心血管疾病》(cvd),而被引用最多的期刊是《糖尿病护理》(Diabetes Care)。该参考网络从1987年到2024年9月30日,确定了19个集群,突出了HUA和糖尿病的关键研究领域,如代谢综合征、泌尿病理学、慢性肾脏疾病(CKD)和心血管疾病。探索糖尿病合并HUA的病理机制和药物干预已成为该领域的研究热点和新兴趋势。结论:本研究首次通过科学计量分析综合了HUA与糖尿病的研究动态,揭示了HUA与糖尿病的分子机制和治疗策略,为今后的临床应用提供了理论见解。
期刊介绍:
Frontiers in Endocrinology is a field journal of the "Frontiers in" journal series.
In today’s world, endocrinology is becoming increasingly important as it underlies many of the challenges societies face - from obesity and diabetes to reproduction, population control and aging. Endocrinology covers a broad field from basic molecular and cellular communication through to clinical care and some of the most crucial public health issues. The journal, thus, welcomes outstanding contributions in any domain of endocrinology.
Frontiers in Endocrinology publishes articles on the most outstanding discoveries across a wide research spectrum of Endocrinology. The mission of Frontiers in Endocrinology is to bring all relevant Endocrinology areas together on a single platform.